Risks and benefits of phase I liver dysfunction studies: should patients with severe liver dysfunction be included in these trials?

C Fountzilas, S Stuart, B Hernandez… - Investigational New …, 2017 - Springer
Introduction The goal of organ dysfunction Phase I trials is to characterize the safety and
pharmacokinetics of novel agents in cancer patients with liver or kidney dysfunction, but the …
被引用次数：4 相关文章

Risks and benefits of phase I liver dysfunction studies: should patients with severe liver dysfunction be included in these trials?

C Fountzilas, S Stuart, B Hernandez… - Investigational …, 2017 - scholars.northwestern.edu
Introduction The goal of organ dysfunction Phase I trials is to characterize the safety and
pharmacokinetics of novel agents in cancer patients with liver or kidney dysfunction, but the …

Risks and benefits of phase I liver dysfunction studies: should patients with severe liver dysfunction be included in these trials?

C Fountzilas, S Stuart, B Hernandez… - Investigational New …, 2017 - infona.pl
Introduction The goal of organ dysfunction Phase I trials is to characterize the safety and
pharmacokinetics of novel agents in cancer patients with liver or kidney dysfunction, but the …

Risks and benefits of phase I liver dysfunction studies: should patients with severe liver dysfunction be included in these trials?

C Fountzilas, S Stuart, B Hernandez… - Investigational New …, 2017 - search.proquest.com
Introduction The goal of organ dysfunction Phase I trials is to characterize the safety and
pharmacokinetics of novel agents in cancer patients with liver or kidney dysfunction, but the …

Risks and benefits of phase I liver dysfunction studies: should patients with severe liver dysfunction be included in these trials?

C Fountzilas, S Stuart, B Hernandez… - Investigational New …, 2017 - scholars.uthscsa.edu
Introduction The goal of organ dysfunction Phase I trials is to characterize the safety and
pharmacokinetics of novel agents in cancer patients with liver or kidney dysfunction, but the …

Risks and benefits of phase I liver dysfunction studies: should patients with severe liver dysfunction be included in these trials?

C Fountzilas, S Stuart, B Hernandez… - Investigational …, 2017 - pubmed.ncbi.nlm.nih.gov
Introduction The goal of organ dysfunction Phase I trials is to characterize the safety and
pharmacokinetics of novel agents in cancer patients with liver or kidney dysfunction, but the …

Risks and benefits of phase I liver dysfunction studies: should patients with severe liver dysfunction be included in these trials?

C Fountzilas, S Stuart, B Hernandez… - Investigational new …, 2017 - europepmc.org
Introduction The goal of organ dysfunction Phase I trials is to characterize the safety and
pharmacokinetics of novel agents in cancer patients with liver or kidney dysfunction, but the …